Despite the substantial advances in understanding breast cancer biology, the clinical management of women with this disease continues to rely almost solely on the tumoral expression of estrogen receptor alpha (ERα), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2). The gene discussed is ESR1; the disease is breast cancer.